Societal perspectives on psychedelics use in clinical context: Development of Concerns and Openness towards Psychedelic Scale (COPS).
Paweł Holas, Justyna Kamińska, Marcin Zajenkowski
Dialogues Clin Neurosci March 6, 2025 DOI: 10.1080/19585969.2025.2470426 via PubMed Central
Summary
AI-generated from the abstractA new scale, the Concerns and Openness towards Psychedelic Scale (COPS), was developed to measure societal attitudes toward clinical psychedelic use. The scale captures two dimensions: concerns about risks and openness to therapeutic benefits. It was validated through surveys and shows good psychometric properties, enabling researchers to assess public perspectives as psychedelic therapy gains attention in mental health treatment.
Study at a glance
| Characteristics | Scale development and validation study Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Keywords | Public health attitudes Medical research Drug policy Mental health treatment |
| Citations | 2 |
| Key finding | The COPS scale reliably measures two dimensions of societal attitudes toward clinical psychedelic use: concerns and openness. |
Abstract
Societal perspectives on psychedelics use in clinical context: Development of Concerns and Openness towards Psychedelic Scale (COPS).